Document ABA Quality Results and Causal Limits

To document ABA quality results variation and causal limits, report raw counts, denominators, units, time windows, measure and cohort versions, missingness, exclusions, and actual change exposure. Show variation over time and meaningful strata when sample size and privacy allow. Compare baseline conditions, concurrent changes, data-quality shifts, and alternative explanations. State the practical meaning and uncertainty without treating association, timing, or a favorable trend as proof of cause.

Define Cleo's quality-result, variation, and causal-limit record

Cleo separates process, implementation, access, client-experience, balancing, and outcome measures. Improvement in one can occur alongside burden or harm in another. The record names the question, decision, authority, people and settings affected, measure version, data source, owner, protection, correction path, and evidence required before any result can be used.

Build Cleo's page-specific fields

Cleo records project question, analysis plan and deviations, measure and cohort versions, source snapshot, counts and denominators, time windows, center and spread when appropriate, missing and excluded states, exposure groups, baseline comparability, run or control chart configuration when used, strata and minimum-cell rule, concurrent changes, data capture changes, unintended effects, client and family input, clinical importance, operational importance, uncertainty, alternative explanations, causal language approved, decision, public-claim boundary, correction, and reproducible output. She uses N/A when a rate has no eligible denominator.

Connect Cleo's results to a decision

Cleo defines which findings support more observation, process repair, clinical review, project adaptation, expansion, or stop. She keeps statistical appearance, practical importance, and client experience separate. A result with small denominators, unstable variation, new missingness, or an adverse balancing measure receives a narrower use. The decision record cites the exact analysis version so a later correction can trigger reconsideration.

Preserve Cleo's client and workforce protections

Cleo records direct client and family input through accessible methods, including AAC, and separates care decisions from project decisions. Essential communication, health, safety, privacy, mobility, food, water, bathroom access, pain care, and emergency help remain protected. Workforce participation, performance review, and employment action use their own authority. Administrative tools can calculate and route; qualified people make clinical, legal, privacy, employment, research, and public-claim decisions.

Version Cleo's evidence chain

Cleo assigns versions to the question, measure, cohort, source snapshot, query, transformation, change package, analysis, dashboard, and report. Each derivative identifies its inputs and generated time. Corrections preserve the earlier result, explain the reason, recalculate affected outputs, and create reconciliation tasks for every clinical, payer, policy, training, governance, or public recipient.

Keep Cleo's units and denominators aligned

Cleo identifies whether the unit is a person, episode, encounter, claim, service line, staff member, observation, opportunity, task, action, site, or period. Numerator and denominator use compatible units and the same maturity rule. Pending, missing, excluded, duplicate, and invalid candidates remain visible in the reconciliation. Counts accompany every rate, and N/A replaces 0% when no unit is eligible.

Separate Cleo's description from cause

Cleo reports timing, association, trend, variation, and concurrent change with precise language. A before-and-after difference, run-chart shift, or improved average can guide investigation and action. It does not by itself isolate the effect of the change. Stronger causal language requires a design and evidence that address plausible alternatives, measurement change, exposure, and chance.

Work through Cleo's fictional example

Cleo reviews 12 weekly rates after a change. The average rises from 68% during baseline to 79% after launch, while denominators range from 8 to 31. Two low-volume weeks have the highest percentages. Missing-data completeness also improves from 82% to 96%, and staffing changes during week four. Cleo reports the pattern, raw counts, and concurrent changes without declaring causation. The example is synthetic and checks arithmetic, source structure, and interpretation. It does not establish a standard, benchmark, legal classification, privacy route, clinical result, causal effect, or outcome for another practice.

Calculate Cleo's measures honestly

The result package includes 12 weekly numerators and denominators, baseline and post-change summaries, missingness, exposure, and client-experience results. A pooled rate and mean weekly percentage remain separately labeled. The fictional 68% and 79% averages cannot be recalculated from this page because the 12 weekly numerator-denominator pairs are not reproduced here.

Address Cleo's main quality risk

A smooth summary can hide small denominators and instability. Cleo keeps the time series, counts, data-quality changes, and balancing measures visible.

Test Cleo's record against hard cases

Cleo tests zero denominator, small week, pooled rate, changing cohort, missingness shift, concurrent staffing, outlier, stratification, privacy cell, and correction.

Review Cleo's decision handoff

Cleo confirms purpose, authority, classification, protections, measure and cohort versions, provenance, missingness, baseline, exposure, analysis, client experience, unwanted effects, actions, sustainment, correction, open work, owner, and next review before releasing the quality-result, variation, and causal-limit record.

Scope Cleo's organizational and professional sources

Cleo uses the CASP Organizational Guidelines public overview for high-level business, clinical-operations, and risk-management scope. CASP sells the details. The BACB Ethics Code applies to covered people and addresses competence, client involvement, consent and assent when applicable, confidentiality, documentation, risk, data, and evaluation. BACB has no separate corporate jurisdiction.

Use Cleo's measure sources as examples

Cleo uses AHRQ Quality Indicators to illustrate technical specifications with a measure description, numerator, denominator, and exclusions. Those indicators use hospital administrative data and are not ABA measures. The AHRQ measure-development page supports objective, standardized, comprehensible numerator, denominator, and data-source specifications. The practice must validate its own measure.

Use Cleo's improvement tools within scope

Cleo uses the AHRQ QI toolkit page for project planning, process mapping, PDSA, run-chart, control-chart, and related tool concepts. The page hosts older primary-care materials and does not prove that one tool fits an ABA question or that a plotted change was caused by the project.

Classify Cleo's project before acting

Cleo uses the HHS OHRP Quality Improvement Activities FAQs for the boundary between activities limited to implementing a practice for care improvement and collecting implementation data, and research designed to contribute to generalizable knowledge. The guidance is nonbinding and predates the revised Common Rule; responsible institutional review remains necessary when classification is uncertain or the activity changes.

Protect Cleo's quality data and access boundary

Cleo uses the HHS Privacy Rule summary for the statement that quality assessment and improvement can be health care operations within HIPAA scope. The HHS access FAQ explains that some quality records using PHI may or may not be in a designated record set depending on whether they are used to make decisions about individuals. Privacy, security, access, state law, contracts, and research rules still require separate analysis.

Choose Cleo's next review trigger

Cleo reopens the quality-result, variation, and causal-limit record when purpose, classification, authority, client input, measure, cohort, source, workflow, exposure, result, missingness, unintended effect, action, public use, correction, or governing source changes. The record preserves the prior version and identifies every affected output, decision, owner, and validation step.

Close Cleo's quality record with limits visible

Review the quality-result, variation, and causal-limit record with the client and authorized people as applicable, qualified clinical and quality leaders, data and privacy owners, and every specialist named in the manifest. Confirm reproducibility, access, burden, causal limits, corrections, and unresolved work. Keep the page draft until every named review is complete.

Document ABA Quality Results, Variation, and Causal Limits